Filing Details

Accession Number:
0001123292-19-000750
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-13 19:32:31
Reporting Period:
2019-05-13
Accepted Time:
2019-05-13 19:32:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661059 Nextcure Inc. NXTC Pharmaceutical Preparations (2834) 475231247
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1728741 Stella Xu C/o Nextcure, Inc.
9000 Virginia Manor Road, Suite 200
Beltsville MD 20705
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-13 978,570 $0.00 978,570 No 4 C Indirect By Quan Venture Fund II, L.P.
Common Stock Acquisiton 2019-05-13 125,000 $15.00 1,103,570 No 4 P Indirect By Quan Venture Fund II, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Quan Venture Fund II, L.P.
No 4 P Indirect By Quan Venture Fund II, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B-2 Preferred Stock Disposition 2019-05-13 7,861,636 $0.00 978,570 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.
  2. The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C. Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P. Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P. except to the extent of her pecuniary interest therein.